Publications
Detailed Information
Depressive Symptoms and Brain Metabolite Alterations in Subjects at Ultra-high Risk for Psychosis: A Preliminary Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Byun, Min Soo | - |
dc.contributor.author | Choi, Jung-Seok | - |
dc.contributor.author | Yoo, So Young | - |
dc.contributor.author | Kang, Do-Hyung | - |
dc.contributor.author | Jang, Dong Pyo | - |
dc.contributor.author | Jung, Myung Hun | - |
dc.contributor.author | Lee, Jong-Min | - |
dc.contributor.author | Kwon, Jun Soo | - |
dc.contributor.author | Jang, Joon Hwan | - |
dc.contributor.author | Jung, Wi Hoon | - |
dc.contributor.author | Choi, Chi-Hoon | - |
dc.date.accessioned | 2012-07-05T00:47:18Z | - |
dc.date.available | 2012-07-05T00:47:18Z | - |
dc.date.issued | 2009-12 | - |
dc.identifier.citation | PSYCHIATRY INVESTIGATION; Vol.6 4; 264-271 | ko_KR |
dc.identifier.issn | 1738-3684 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78526 | - |
dc.description.abstract | Objective Recent neuroimaging studies have suggested that brain changes occur in subjects at Ultra-high risk (UHR) for psychosis while experiencing prodromal symptoms, among which depression may increase the risk of developing a psychotic disorder. The goal of this study is to examine brain metabolite levels in the anterior cingulate cortex, the left dorsolateral prefrontal cortex and the left thalamus in Subjects at UHR for psychosis and to compare brain metabolite levels between the UHR subjects with comorbid major depressive disorder and healthy controls. Methods Proton magnetic resonance spectroscopy was used to examine brain metabolite levels. Twenty UHR subjects and 20 age- and intelligence quotient (IQ)-matched healthy controls were included in this study. Results Overall, no significant differences were observed in any metabolite between the UHR and healthy control group. However, UHR subjects with major depressive disorder showed significantly higher myo-inositol (Ins) levels in the left thalamus, compared to the healthy control. Conclusion Our results demonstrate that increased thalamic Ins level is associated with prodromal depressive symptoms. Further longitudinal follow-up Studies with larger UHR sample sizes are required to investigate the function of Ins concentrations as a biomarker Of Vulnerability to psychosis. Psychiatry Invest 2009;6:264-271 | ko_KR |
dc.description.sponsorship | This paper was supported by a grant (M10644020003-08N4402-
00310) from the Cognitive Neuroscience Program of the Korean Ministry of Science and Technology of the Republic of Korea. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | KOREAN NEUROPSYCHIATRIC ASSOC | ko_KR |
dc.subject | Depression | ko_KR |
dc.subject | Magnetic resonance spectroscopy | ko_KR |
dc.subject | Ultra-high risk | ko_KR |
dc.subject | Schizophrenia | ko_KR |
dc.title | Depressive Symptoms and Brain Metabolite Alterations in Subjects at Ultra-high Risk for Psychosis: A Preliminary Study | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 변민수 | - |
dc.contributor.AlternativeAuthor | 최정석 | - |
dc.contributor.AlternativeAuthor | 유소영 | - |
dc.contributor.AlternativeAuthor | 강도형 | - |
dc.contributor.AlternativeAuthor | 최치훈 | - |
dc.contributor.AlternativeAuthor | 장동표 | - |
dc.contributor.AlternativeAuthor | 정이훈 | - |
dc.contributor.AlternativeAuthor | 정명훈 | - |
dc.contributor.AlternativeAuthor | 장준환 | - |
dc.contributor.AlternativeAuthor | 이종민 | - |
dc.contributor.AlternativeAuthor | 권준수 | - |
dc.identifier.doi | 10.4306/pi.2009.6.4.264 | - |
dc.citation.journaltitle | PSYCHIATRY INVESTIGATION | - |
dc.description.citedreference | Yoo SY, 2009, SCHIZOPHR RES, V111, P86, DOI 10.1016/j.schres.2009.03.036 | - |
dc.description.citedreference | Wood SJ, 2009, NEUROBIOL DIS, V33, P354, DOI 10.1016/j.nbd.2008.11.018 | - |
dc.description.citedreference | Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002 | - |
dc.description.citedreference | Aydin K, 2008, BIOL PSYCHIAT, V64, P750, DOI 10.1016/j.biopsych.2008.04.007 | - |
dc.description.citedreference | Choi JS, 2008, PROG NEURO-PSYCHOPH, V32, P1326, DOI 10.1016/j.pnpbp.2008.04.011 | - |
dc.description.citedreference | Whalley HC, 2008, J AFFECT DISORDERS, V109, P99, DOI 10.1016/j.jad.2007.11.009 | - |
dc.description.citedreference | Young KA, 2008, BRIT J PSYCHIAT, V192, P285, DOI 10.1192/bjp.bp.107.039180 | - |
dc.description.citedreference | Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020 | - |
dc.description.citedreference | Borgwardt SJ, 2007, BIOL PSYCHIAT, V61, P1148, DOI 10.1016/j.biopsych.2006.08.009 | - |
dc.description.citedreference | Jessen F, 2006, SCHIZOPHR RES, V87, P81, DOI 10.1016/j.schres.2006.06.011 | - |
dc.description.citedreference | Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139 | - |
dc.description.citedreference | Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964 | - |
dc.description.citedreference | Caetano SC, 2005, NEUROSCI LETT, V384, P321, DOI 10.1016/j.neulet.2005.04.099 | - |
dc.description.citedreference | Kim H, 2005, HUM PSYCHOPHARM CLIN, V20, P309, DOI 10.1002/hup.693 | - |
dc.description.citedreference | Jang DP, 2005, MAGNET RESON MED, V53, P708, DOI 10.1002/mrm.20387 | - |
dc.description.citedreference | Silverstone PH, 2005, BIPOLAR DISORD, V7, P1 | - |
dc.description.citedreference | Johnstone EC, 2005, BRIT J PSYCHIAT, V186, P18 | - |
dc.description.citedreference | Neumeister A, 2004, ARCH GEN PSYCHIAT, V61, P765 | - |
dc.description.citedreference | Theberge J, 2004, PSYCHIAT RES-NEUROIM, V131, P107, DOI 10.1016/j.pscychresns.2004.04.002 | - |
dc.description.citedreference | Young KA, 2004, AM J PSYCHIAT, V161, P1270 | - |
dc.description.citedreference | Tibbo P, 2004, AM J PSYCHIAT, V161, P1116 | - |
dc.description.citedreference | Yung AR, 2004, SCHIZOPHR RES, V67, P131, DOI 10.1016/S0920-9964(03)00192-0 | - |
dc.description.citedreference | Smith EA, 2003, BIOL PSYCHIAT, V54, P1399, DOI 10.1016/S0006-3223(03)00474-8 | - |
dc.description.citedreference | Vythilingam M, 2003, BIOL PSYCHIAT, V54, P744, DOI 10.1016/S0006-3223(03)01908-X | - |
dc.description.citedreference | Gruber S, 2003, INVEST RADIOL, V38, P403, DOI 10.1097/01.rli.0000073446.43445.20 | - |
dc.description.citedreference | Yucel M, 2003, BRIT J PSYCHIAT, V182, P518 | - |
dc.description.citedreference | Yoon U, 2003, ANN BIOMED ENG, V31, P441, DOI 10.1114/1.1557973 | - |
dc.description.citedreference | Wood SJ, 2003, SCHIZOPHRENIA BULL, V29, P831 | - |
dc.description.citedreference | Farchione TR, 2002, BIOL PSYCHIAT, V52, P86 | - |
dc.description.citedreference | Malhi GS, 2002, AUST NZ J PSYCHIAT, V36, P31 | - |
dc.description.citedreference | Auer DP, 2001, SCHIZOPHR RES, V52, P87 | - |
dc.description.citedreference | Drevets WC, 2000, BIOL PSYCHIAT, V48, P813 | - |
dc.description.citedreference | Hafner H, 1999, ACTA PSYCHIAT SCAND, V100, P105 | - |
dc.description.citedreference | Frey R, 1998, J PSYCHIAT RES, V32, P411 | - |
dc.description.citedreference | FIRST MB, 1996, STRUCTURED CLIN INTE | - |
dc.description.citedreference | PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672 | - |
dc.description.citedreference | MICHAELIS T, 1993, RADIOLOGY, V187, P219 | - |
dc.description.citedreference | DAGER SR, 1992, NEUROPSYCHOPHARMACOL, V6, P249 | - |
dc.description.citedreference | YUM TH, 1992, MANUAL KOREAN WECHSL | - |
dc.description.citedreference | KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261 | - |
dc.description.citedreference | LUKOFF D, 1986, SCHIZOPHRENIA BULL, V12, P578 | - |
dc.description.citedreference | HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278 | - |
dc.description.citedreference | HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50 | - |
dc.description.tc | 1 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.